GlassScriptPhysician profile
Erik Zeegen
NPI 1427039437
$409,239.32
in general payments reported to CMS, 2019-2025
11 companies · $196K in 2025
The $196K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $22K · 2021: $14K · 2022: $11K · 2023: $121K · 2024: $43K · 2025: $196K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $151K · Consulting Fee: $101K · Royalty Or License: $73K · Travel and Lodging: $34K · Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $150,705.00 |
| Consulting Fee | $101,097.10 |
| Royalty Or License | $72,526.69 |
| Travel and Lodging | $33,778.83 |
| Food and Beverage | $2,501.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $383,275.83 | 2019-2025 | Persona, Rosa, Z1 Hip System |
| Smith+Nephew, INC. | $13,104.84 | 2019-2025 | Real Intelligence |
| Medical Device Business Services, INC. | $9,163.74 | 2023 | Surgicel Nu-Knit, Vistaseal, Dermabond |
| Ethicon US, LLC | $3,267.43 | 2023 | Dermabond, Stratafix |
| Stryker Corporation | $132.81 | 2019 | |
| Siemens Medical Solutions USA, INC. | $119.74 | 2021 | |
| Depuy Synthes Sales INC. | $101.39 | 2019 | |
| Innovation Technologies INC | $37.40 | 2023 | Irrisept |
| Heron Therapeutics, INC. | $21.59 | 2025 | Zynrelef |
| Dynasplint Systems INC. | $14.55 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Zeegen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.